Found 197 matching trials
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
PHASE2This research study is testing whether a weekly medication called tirzepati...
Location
Institut de Recherches Cliniques de MontrƩal
Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD
PHASE1A study to evaluate the PK and PD of oral IN-105 (Insulin Tregopil) w.r.t. ...
Location
Multiple Locations
Apidra Children & Adolescents Study
PHASE4Primary Objective:
Evaluate the percentage of patients achieving glycosyla...
Location
Administrative office
Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options
NAThis study evaluates the prevalence of gastric emptying (GE) in type 1 diab...
Location
Dept. of "Medicina Clinica e Chirurgia" of Federico II University
Automated Insulin Delivery Versus Daily Injections for Hospital Diabetes Care
NAAim
The investigators aim to investigate if automated insulin delivery sys...
Location
University Hospital of Graz
To Test the Effect of Selected Fibres and Flours in Flat Bread on Post-Prandial Blood Glucose and Insulin Responses in Healthy Indian Population
NADouble-blind, randomized, controlled, cross-over design with 3 test product...
Location
Lambda Therapeutics Research Ltd (LTRL)
Prandial Insulin Dosing in Hospitalized Patients
PHASE4The purpose of this study is to determine whether mealtime insulin results ...
Location
The Ohio State University
Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies
NAExcessive daytime sleepiness (EDS) is observed in 30 to 50 % of patients wi...
Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)
PHASE4BEYOND represents an open-label, parallel, three-arm randomized controlled ...
Location
Unit of Endocrinology and Metabolic Diseases
The Safety and Efficacy of MK-1293 Versus Lantus⢠in Participants With Type 2 Diabetes Mellitus (MK-1293-006)
PHASE3This 24-week study is a safety and efficacy comparison of MK-1293 and Lantu...
Location
Multiple Locations